Vera Therapeutics is trading at $30.60, up 4.01%, with no clear company-specific catalyst emerging for its October 7, 2026 gain.
- Company announcements found in available reporting were earlier.
- Treasury yields and oil prices rose as markets focused on Federal Reserve minutes. Biotech also declined broadly, but those sector losses do not explain Vera Therapeuticsβ gain.